ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
Abstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, wit...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2018-12-01
|
Series: | Annals of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13613-018-0467-6 |
id |
doaj-67701136591047eab1bdf8f4a7821487 |
---|---|
record_format |
Article |
spelling |
doaj-67701136591047eab1bdf8f4a78214872020-11-25T02:54:00ZengSpringerOpenAnnals of Intensive Care2110-58202018-12-018111110.1186/s13613-018-0467-6ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patientsA. S. Truche0S. Perinel Ragey1B. Souweine2S. Bailly3L. Zafrani4L. Bouadma5C. Clec’h6M. Garrouste-Orgeas7G. Lacave8C. Schwebel9F. Guebre-Egziabher10C. Adrie11A. S. Dumenil12Ph. Zaoui13L. Argaud14S. Jamali15D. Goldran Toledano16G. Marcotte17J. F. Timsit18M. Darmon19UMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, Croix Rousse Hospital, Lyon University HospitalMedical Intensive Care Unit, Gabriel Montpied University HospitalUMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, AP-HP, Saint Louis HospitalMedical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat Hospital, Paris Diderot UniversityIntensive Care Unit, AP-HP, Avicenne HospitalIntensive Care Unit, Saint Joseph Hospital NetworkMedical Intensive Care Unit, André Mignot HospitalMedical Intensive Care Unit, Grenoble University HospitalNephrology Dialysis Renal Transplantation, Grenoble University HospitalPhysiology Department, Cochin University Hospital, Assistance Publique, Hôpitaux de Paris (AP-HP), Paris Descartes University des, Sorbonne CiteMedical-Surgical Intensive Care Unit, AP-HP, Antoine Béclère University HospitalNephrology Dialysis Renal Transplantation, Grenoble University HospitalMedical Intensive Care Unit, Edouard Herriot University HospitalCritical Care Medicine Unit, Dourdan HospitalIntensive Care Unit, Gonesse HospitalSurgical ICU, Edouard Herriot University HospitalUMR 1137 - IAME Team 5 – DeSCID : Decision SCiences in Infectious Diseases, Control and Care, Inserm/Paris Diderot University, Sorbonne Paris CitéMedical Intensive Care Unit, AP-HP, Saint Louis HospitalAbstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, with 28-day ICU mortality as primary end point, considering discharge alive as a competing event and taking into account time-dependent nature of renal recovery. Renal recovery was defined as a decrease of at least one KDIGO class compared to the previous day. Setting 23 French ICUs. Patients Patients of a French multicentric observational cohort were included if they suffered from AKI at ICU admission between 1996 and 2015. Intervention None. Results A total of 5242 patients were included. Initial severity according to KDIGO creatinine definition was AKI stage 1 for 2458 patients (46.89%), AKI stage 2 for 1181 (22.53%) and AKI stage 3 for 1603 (30.58%). Crude 28-day ICU mortality according to AKI severity was 22.74% (n = 559), 27.69% (n = 327) and 26.26% (n = 421), respectively. Renal recovery was experienced by 3085 patients (58.85%), and its rate was significantly different between AKI severity stages (P < 0.01). Twenty-eight-day ICU mortality was independently lower in patients experiencing renal recovery [CSHR 0.54 (95% CI 0.46–0.63), P < 0.01]. Lastly, RRT requirement was strongly associated with persistent AKI whichever threshold was chosen between day 2 and 7 to delineate transient from persistent AKI. Conclusions Short-term renal recovery, according to several definitions, was independently associated with higher mortality and RRT requirement. Moreover, distinction between transient and persistent AKI is consequently a clinically relevant surrogate outcome variable for diagnostic testing in critically ill patients.http://link.springer.com/article/10.1186/s13613-018-0467-6Acute kidney injuryIntensive care unitRenal recoveryRenal replacement therapyEpidemiology and outcome |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
A. S. Truche S. Perinel Ragey B. Souweine S. Bailly L. Zafrani L. Bouadma C. Clec’h M. Garrouste-Orgeas G. Lacave C. Schwebel F. Guebre-Egziabher C. Adrie A. S. Dumenil Ph. Zaoui L. Argaud S. Jamali D. Goldran Toledano G. Marcotte J. F. Timsit M. Darmon |
spellingShingle |
A. S. Truche S. Perinel Ragey B. Souweine S. Bailly L. Zafrani L. Bouadma C. Clec’h M. Garrouste-Orgeas G. Lacave C. Schwebel F. Guebre-Egziabher C. Adrie A. S. Dumenil Ph. Zaoui L. Argaud S. Jamali D. Goldran Toledano G. Marcotte J. F. Timsit M. Darmon ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients Annals of Intensive Care Acute kidney injury Intensive care unit Renal recovery Renal replacement therapy Epidemiology and outcome |
author_facet |
A. S. Truche S. Perinel Ragey B. Souweine S. Bailly L. Zafrani L. Bouadma C. Clec’h M. Garrouste-Orgeas G. Lacave C. Schwebel F. Guebre-Egziabher C. Adrie A. S. Dumenil Ph. Zaoui L. Argaud S. Jamali D. Goldran Toledano G. Marcotte J. F. Timsit M. Darmon |
author_sort |
A. S. Truche |
title |
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients |
title_short |
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients |
title_full |
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients |
title_fullStr |
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients |
title_full_unstemmed |
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients |
title_sort |
icu survival and need of renal replacement therapy with respect to aki duration in critically ill patients |
publisher |
SpringerOpen |
series |
Annals of Intensive Care |
issn |
2110-5820 |
publishDate |
2018-12-01 |
description |
Abstract Background Transient and persistent acute kidney injury (AKI) could share similar physiopathological mechanisms. The objective of our study was to assess prognostic impact of AKI duration on ICU mortality. Design Retrospective analysis of a prospective database via cause-specific model, with 28-day ICU mortality as primary end point, considering discharge alive as a competing event and taking into account time-dependent nature of renal recovery. Renal recovery was defined as a decrease of at least one KDIGO class compared to the previous day. Setting 23 French ICUs. Patients Patients of a French multicentric observational cohort were included if they suffered from AKI at ICU admission between 1996 and 2015. Intervention None. Results A total of 5242 patients were included. Initial severity according to KDIGO creatinine definition was AKI stage 1 for 2458 patients (46.89%), AKI stage 2 for 1181 (22.53%) and AKI stage 3 for 1603 (30.58%). Crude 28-day ICU mortality according to AKI severity was 22.74% (n = 559), 27.69% (n = 327) and 26.26% (n = 421), respectively. Renal recovery was experienced by 3085 patients (58.85%), and its rate was significantly different between AKI severity stages (P < 0.01). Twenty-eight-day ICU mortality was independently lower in patients experiencing renal recovery [CSHR 0.54 (95% CI 0.46–0.63), P < 0.01]. Lastly, RRT requirement was strongly associated with persistent AKI whichever threshold was chosen between day 2 and 7 to delineate transient from persistent AKI. Conclusions Short-term renal recovery, according to several definitions, was independently associated with higher mortality and RRT requirement. Moreover, distinction between transient and persistent AKI is consequently a clinically relevant surrogate outcome variable for diagnostic testing in critically ill patients. |
topic |
Acute kidney injury Intensive care unit Renal recovery Renal replacement therapy Epidemiology and outcome |
url |
http://link.springer.com/article/10.1186/s13613-018-0467-6 |
work_keys_str_mv |
AT astruche icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT sperinelragey icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT bsouweine icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT sbailly icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT lzafrani icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT lbouadma icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT cclech icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT mgarrousteorgeas icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT glacave icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT cschwebel icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT fguebreegziabher icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT cadrie icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT asdumenil icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT phzaoui icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT largaud icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT sjamali icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT dgoldrantoledano icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT gmarcotte icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT jftimsit icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients AT mdarmon icusurvivalandneedofrenalreplacementtherapywithrespecttoakidurationincriticallyillpatients |
_version_ |
1724723068053487616 |